Explores Alzheimer's disease, anxiety, pain, and the renin-angiotensin system, including the development of the first renin inhibitor for clinical treatment.
Explores proteinopathy mapping, connecting proteotoxicity to intrinsic functions of aggregation-prone proteins, with a focus on alpha-synuclein and Parkinson's Disease.
Explores bacterial toxin uptake mechanisms, membrane interactions, and cluster formation, emphasizing the interplay between toxins, membranes, and cellular machinery.
